{"id":454813,"date":"2021-03-10T09:03:20","date_gmt":"2021-03-10T14:03:20","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=454813"},"modified":"2021-03-10T09:03:20","modified_gmt":"2021-03-10T14:03:20","slug":"geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/","title":{"rendered":"GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <strong><br \/>\n          <em>GeoVax Chairman &amp; CEO David Dodd to Present Corporate Overview<\/em><br \/>\n        <\/strong><br \/>\n        \n      <\/p>\n<p align=\"start\">\n        <strong><br \/>\n          <em>GeoVax CSO, Mark Newman, PhD, to Participate in Immuno-Oncology Panel Discussion<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p>ATLANTA, GA, March  10, 2021  (GLOBE NEWSWIRE) &#8212; via <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aN5xEpW2ExGSVHYWx4NJqyVP8PzhlqbFuNflGvhCvAiQG6lpVoyj9kTqHgYa8ACuhzrBIQPlXZAWBZGUSi4C_BVSPv9YQN4sRnsSFl8lOhk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>NewMediaWire<\/u><\/a> &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Wf25v9B9h0uSQpSdnXBoHTv-MD78RjKT3MOxn7JTcY9Qv2KDBBywpagt0MsE8XXxHeeikt0ncyMuixPkYBfqsg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">GeoVax Labs, Inc<\/a>. (NasdaqCM: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, has been invited to present at Maxim Group\u2019s\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GDKL8g44J36y1keK-glzWxJ6ZBB0wU6_7-Nz5DNqS0IHWbxkMN0Mh3fgAhDjsCTcC4xLJgDgRaj6X_pDkCKU6LPXneTfoAvLQrjTz_gfMTY0GErGjIVcHsbQnbqQ7Twh_WH8ygTfHavn5NrU4FPtRjkc6UoGn0FteBJpmbiT2kJHVnQadn-kCoWPddgkCjQX\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><em>Inaugural Emerging Growth Virtual Conference<\/em><\/a>\u00a0to be held March 17-18.<\/p>\n<p>During this virtual conference, GeoVax\u2019s Chairman and CEO, David Dodd, will present an overview of GeoVax\u2019s immunotherapy and vaccine research and development efforts, focusing on the Company\u2019s COVID-19 and cancer immunotherapy programs.\u00a0 GeoVax\u2019s Chief Scientific Officer, Mark Newman, PhD, will also participate in a panel discussion on recent developments in cancer vaccines and immuno-oncology.\u00a0 Investors can view the presentation and the panel by registering for the conference\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KZnlODyRMvcRxkQzREKDq5vaI5goFdyXf2mlHD5Vo5sSnO7CogW9Jz4cVl9BR96qm28h7I7XjHChkMnjJBWrkE7gNV0WDZUPhmp5NtO-YkMG0D9qpz9dvLSVbou2rdkL\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">here<\/a>\u00a0and can also request a 1&#215;1 meeting with Mr. Dodd to be arranged following the conclusion of the conference.<\/p>\n<p>\n        <strong>About GeoVax<\/strong>\n      <\/p>\n<p>GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On this platform, MVA, a large virus capable of carrying several vaccine antigens, expresses proteins that assemble into VLP immunogens in the person receiving the vaccine. The production of VLPs in the person being vaccinated can mimic virus production in a natural infection, stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. The MVA-VLP derived vaccines can elicit durable immune responses in the host similar to a live-attenuated virus, while providing the safety characteristics of a replication-defective vector.<\/p>\n<p>GeoVax\u2019s current development programs are focused on preventive vaccines against COVID-19, HIV, Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, as well as therapeutic vaccines against multiple cancers. The Company has designed a preventive HIV vaccine candidate to fight against the subtype of HIV prevalent in the commercial markets of the Americas, Western Europe, Japan, and Australia; human clinical trials for this program are managed by the HIV Vaccine Trials Network (HVTN) with the support of the National Institutes of Health (NIH). GeoVax\u2019s HIV vaccine is also part of two separate collaborative efforts to apply its innovative gene therapy approach toward a functional cure for HIV.<\/p>\n<p>GeoVax Labs, Inc.<br \/> 6783847220<br \/> investor@geovax.com<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzE1MiM0MDU2MDgyIzUwMDAzMjA1NQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/e75be12f-5792-401d-81db-6ad4f3705f50\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>GeoVax Chairman &amp; CEO David Dodd to Present Corporate Overview GeoVax CSO, Mark Newman, PhD, to Participate in Immuno-Oncology Panel Discussion ATLANTA, GA, March 10, 2021 (GLOBE NEWSWIRE) &#8212; via NewMediaWire &#8212; GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, has been invited to present at Maxim Group\u2019s\u00a0Inaugural Emerging Growth Virtual Conference\u00a0to be held March 17-18. During this virtual conference, GeoVax\u2019s Chairman and CEO, David Dodd, will present an overview of GeoVax\u2019s immunotherapy and vaccine research and development efforts, focusing on the Company\u2019s COVID-19 and cancer immunotherapy programs.\u00a0 GeoVax\u2019s Chief Scientific Officer, Mark Newman, PhD, will also participate in a panel discussion on recent developments in cancer vaccines and immuno-oncology.\u00a0 Investors &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-454813","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GeoVax Chairman &amp; CEO David Dodd to Present Corporate Overview GeoVax CSO, Mark Newman, PhD, to Participate in Immuno-Oncology Panel Discussion ATLANTA, GA, March 10, 2021 (GLOBE NEWSWIRE) &#8212; via NewMediaWire &#8212; GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, has been invited to present at Maxim Group\u2019s\u00a0Inaugural Emerging Growth Virtual Conference\u00a0to be held March 17-18. During this virtual conference, GeoVax\u2019s Chairman and CEO, David Dodd, will present an overview of GeoVax\u2019s immunotherapy and vaccine research and development efforts, focusing on the Company\u2019s COVID-19 and cancer immunotherapy programs.\u00a0 GeoVax\u2019s Chief Scientific Officer, Mark Newman, PhD, will also participate in a panel discussion on recent developments in cancer vaccines and immuno-oncology.\u00a0 Investors &hellip; Continue reading &quot;GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-10T14:03:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzE1MiM0MDU2MDgyIzUwMDAzMjA1NQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference\",\"datePublished\":\"2021-03-10T14:03:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\\\/\"},\"wordCount\":406,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzE1MiM0MDU2MDgyIzUwMDAzMjA1NQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\\\/\",\"name\":\"GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzE1MiM0MDU2MDgyIzUwMDAzMjA1NQ==\",\"datePublished\":\"2021-03-10T14:03:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzE1MiM0MDU2MDgyIzUwMDAzMjA1NQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzE1MiM0MDU2MDgyIzUwMDAzMjA1NQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference - Market Newsdesk","og_description":"GeoVax Chairman &amp; CEO David Dodd to Present Corporate Overview GeoVax CSO, Mark Newman, PhD, to Participate in Immuno-Oncology Panel Discussion ATLANTA, GA, March 10, 2021 (GLOBE NEWSWIRE) &#8212; via NewMediaWire &#8212; GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, has been invited to present at Maxim Group\u2019s\u00a0Inaugural Emerging Growth Virtual Conference\u00a0to be held March 17-18. During this virtual conference, GeoVax\u2019s Chairman and CEO, David Dodd, will present an overview of GeoVax\u2019s immunotherapy and vaccine research and development efforts, focusing on the Company\u2019s COVID-19 and cancer immunotherapy programs.\u00a0 GeoVax\u2019s Chief Scientific Officer, Mark Newman, PhD, will also participate in a panel discussion on recent developments in cancer vaccines and immuno-oncology.\u00a0 Investors &hellip; Continue reading \"GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-10T14:03:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzE1MiM0MDU2MDgyIzUwMDAzMjA1NQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference","datePublished":"2021-03-10T14:03:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/"},"wordCount":406,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzE1MiM0MDU2MDgyIzUwMDAzMjA1NQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/","name":"GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzE1MiM0MDU2MDgyIzUwMDAzMjA1NQ==","datePublished":"2021-03-10T14:03:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzE1MiM0MDU2MDgyIzUwMDAzMjA1NQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzE1MiM0MDU2MDgyIzUwMDAzMjA1NQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/geovax-to-participate-in-maxim-groups-inaugural-emerging-growth-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GeoVax to Participate in Maxim Group\u2019s Inaugural Emerging Growth Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=454813"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454813\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=454813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=454813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=454813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}